Pharmafile Logo

Patients and data tracking

- PMLiVE

Study provides new insights into Alzheimer’s disease

The study used the genomes of 100,000 people with Alzheimer’s and 600,000 healthy individuals

- PMLiVE

Galderma launches Rosacea Space to raise awareness

The platform invites people to share their experiences and what rosacea means to them

- PMLiVE

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...

Wilmington Healthcare

- PMLiVE

FDA delays Merck’s pneumococcal vaccine Vaxneuvance

It is predicted that the vaccine could make over $1bn in peak sales

- PMLiVE

Sanofi launches Diversity, Equity & Inclusion Board

The Board is the first of its kind in the pharma industry to have outside advisors

What do we really value as a society?

'A third of older people in our society die with dementia. A third.' Will the government invest more to help find a cure? (Article written 14th June 2021).

Dice Medical Communications

Online Advisory Boards: Top 10 Frequently Asked Questions

It’s hard to imagine a time when some people in the life science industry had never attended a web meeting. Yet, that’s the reality we were living in just two...

Impetus Digital

Roche Basel Switzerland

Roche shares new positive Ocrevus data for MS patients

The CONSONANCE trial showed treatment with Ocrevus resulted in a majority of patients experiencing no disease progression

- PMLiVE

Novartis restructures organisation to support growth and innovation

The new operational structure will involve integrating pharmaceuticals and oncology business units into an Innovative Medicines business

Webcast: Demand Assessment

Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

Inizio

- PMLiVE

The changing face of the medical science liaison

By Carol Heggie (pictured left) and David Williams (pictured right)

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links